Wide Ranks

CERO

CERo Therapeutics Holdings, Inc

0.2023

Top Statistics
Market Cap 30 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 0.48 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 3 M Total Cash Per Share 0.0720 Total Debt 2 M
Total Debt To Equity Current Ratio 0.48 Book Value Per Share -2.27
All Measures
Short Ratio 29.00 % Message Board Id finmb_1673740339 Shares Short Prior Month 2 M
City South San Francisco Uuid c96e7212-658f-3054-8625-d2aafea7c5eb Previous Close 0.1470
First Trade Date Epoch Utc 1 B Book Value -2.27 Beta -0.4630
Total Debt 2 M Volume 63 M Fifty Two Week Low 0.0640
Total Cash Per Share 0.0720 Shares Short Previous Month Date 1 B Max Age 86400
Sand P52 Week Change 0.3133 Net Income To Common -2753744 Short Percent Of Float 0.0208
Implied Shares Outstanding 150 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 137 M Average Volume10days 137 M Total Cash 3 M
Next Fiscal Year End 1 B Held Percent Insiders 0.5542 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 0.1470
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 0.1237
Open 0.1499 Free Cashflow 14 M State CA
Dividend Yield 0.00 % Return On Assets -0.4528 Time Zone Short Name EST
Trailing Eps -1.19 Day Low 0.1499 Address1 201 Haskins Way
Shares Outstanding 150 M Price Hint 4 Target High Price 0.0000
Website https://www.cero.bio 52 Week Change -0.9814 Average Volume 65 M
Recommendation Key none Forward Eps 0.0000 Quick Ratio 42.50 %
Is_sp_500 False Regular Market Day High 0.2549 Profit Margins 0.00 %
Fifty Two Week High 12.80 Day High 0.2549 Shares Short 1 M
Regular Market Open 0.1499 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.0107 Operating Cashflow -6629971
Currency USD Time Zone Full Name America/New_York Market Cap 30 M
Is_nasdaq_100 False Zip 94080 Quote Type EQUITY
Industry Biotechnology Long Name CERo Therapeutics Holdings, Inc. Regular Market Day Low 0.1499
Held Percent Institutions 0.0508 Current Price 0.2023 Address2 Suite 230
Financial Currency USD Current Ratio 0.48 Industry Disp Biotechnology
Country United States Float Shares 22 M Two Hundred Day Average 0.8948
Enterprise Value 20 M Forward PE 0.0000 Regular Market Volume 63 M
Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.

Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies.

The company was incorporated in 2021 and is based in South San Francisco, California.